查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786454

DNA合成器的全球市場

DNA Synthesizer
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 221 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球 DNA 合成器市場規模將達到 7.878 億美元

全球DNA合成器市場規模預計在2024年為3.225億美元，到2030年將達到7.878億美元，在2024-2030年的分析期間內，複合年成長率為16.1%。桌上型DNA合成器是本報告分析的細分市場之一，預計其複合年成長率為17.9%，到分析期結束時市場規模將達到5.498億美元。大型DNA合成器細分市場在分析期間的複合年成長率預計為12.5%。

美國市場規模估計為 8,480 萬美元，中國市場預計複合年成長率為 15.0%

美國DNA合成器市場規模預計在2024年達到8,480萬美元。作為世界第二大經濟體，中國市場規模預計將在2030年達到1.211億美元，2024年至2030年的複合年成長率為15.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為15.0%和13.7%。在歐洲，德國的複合年成長率預計將達到11.6%。

全球 DNA 合成器市場 - 主要趨勢與促進因素摘要

合成 DNA 會成為下一波生技創新的動力嗎？

對合成DNA日益成長的需求正在推動生物技術的模式轉移，而DNA合成儀正是這項轉變的核心。 DNA合成儀能夠自動組裝客製化DNA序列，已成為研究、診斷、治療和工業生物技術的重要工具。隨著合成生物學的發展，科學家正在利用合成DNA設計基因迴路、創造新生物，並從零開始建構整個基因組。快速高精度地生產寡核苷酸和基因片段的能力正在加速CRISPR基因編輯、mRNA療法、疫苗開發、代謝工程等領域的研究。例如，在新冠疫情期間，研究人員利用合成儀快速建構病毒基因原型以生產抗原，凸顯了合成DNA在疫苗開發中的價值。此外，隨著DNA合成成本的持續下降，越來越多的研究機構和生技新興企業正在將合成儀納入其實驗室，以降低外包成本並縮短計劃週轉時間。學術機構、製藥公司和委外研發機構(CRO) 越來越依賴內部合成能力，以實現更靈活、高通量的工作流程。 DNA 合成儀如今正推動從單基因合成向大規模 DNA 製造的轉變，用於基因組組裝、基因文庫和基於 DNA 的數據存儲實驗。幾乎所有生命科學領域對合成 DNA 的需求都在不斷成長，這使得 DNA 合成儀成為推動未來研究、創新和生物製造發展的策略性技術。

技術進步如何提高 DNA 合成的速度、精確度和規模？

近年來，DNA合成技術取得了顯著進步，這得益於旨在提高速度、準確性、產量和可擴展性的創新。傳統的基於亞磷醯胺的固相合成長期以來一直是短寡核苷酸的黃金標準，但它在序列長度和錯誤累積方面有其限制。為了克服這些障礙，酵素DNA合成等新技術應運而生。這些方法利用工程聚合酵素和無模板反應，在較溫和的水性條件下合成更長、更準確的DNA鏈。此外，基於微陣列的合成平台如今能夠在單一晶片上並行產生數千個DNA序列，從而降低成本並支援基因文庫和篩檢分析等大規模應用。與機器人技術和自動化技術的結合使DNA合成器更易於使用，能夠以最少的人工干預實現無人值守的合成。即時監控系統和先進的品管工具（例如質譜和毛細管電泳）正在整合到下一代合成器中，以確保產品的純度和產量。人工智慧和機器學習演算法也被用於即時預測合成誤差並最佳化通訊協定，從而提高可重複性和客製化程度。這些技術創新正在將DNA合成的範圍從標準實驗室應用擴展到臨床研究、精準醫療和工業規模生產。現代DNA合成儀不斷突破合成工程的界限，在重塑基因組學的發展速度和可能性方面發揮關鍵作用。

不斷擴大的最終用戶群是否會重塑 DNA 合成器市場的商業策略？

DNA合成儀市場以終端用戶群的多元化為特點，這迫使製造商客製化其技術和服務，以滿足不同程度的專業技能、應用重點和吞吐量需求。學術機構和核心實驗室仍然是主要用戶，他們利用合成儀進行基礎遺傳和細胞生物學研究。然而，製藥公司、診斷公司和合成生物學新興企業的採用率正在迅速成長，這些公司需要大規模、特定應用的DNA合成，以用於臨床試驗、治療方法開發和產品創新。活躍於農業、工業酵素和生質燃料領域的公司也正在使用DNA合成儀來最佳化基因改造作物（GMO）和微生物生產系統。人們對DNA資料儲存日益成長的興趣催生了一個利基市場，即專門用於將數位資料編碼到DNA鏈中的高容量合成儀。隨著需求的多樣化，商業策略也不斷發展。製造商現在為低吞吐量實驗室提供桌上型合成儀，為工業用戶提供高容量平台，並為希望在不擁有實體設備的情況下存取資料的機構提供雲端基礎的合成即服務模式。這些服務模式尤其受到新興企業和學術研究人員的青睞，他們尋求以經濟高效的方式獲取高品質DNA，而無需投入大量資金。此外，培訓計畫、軟體整合和按需支援正成為商業性服務的重要組成部分，使各層級的使用者都能有效地操作和維護合成儀。透過調整技術以適應不同使用者群體的需求，企業正在鞏固其市場地位，並促進生命科學領域內部DNA合成應用的擴展。

推動全球 DNA 合成機器需求的主要市場促進因素是什麼？

DNA合成儀市場的成長受到多種相互關聯的因素所驅動，這些因素根植於技術創新、應用擴展和不斷變化的用戶需求。其中一個關鍵促進因素是合成生物學在治療、農業和生物製造等領域的日益普及，在這些領域，合成DNA是設計生物系統和客製化生物體的基礎。疫苗開發中對快速原型製作的需求，尤其是基於mRNA和DNA的平台，也刺激了高通量DNA合成儀的投資。此外，CRISPR和基因編輯研究領域的不斷擴展，推動了對精準設計的嚮導RNA和供體模板的需求，從而進一步推動了合成儀的利用率。另一個成長要素是對分散式內部DNA合成解決方案的需求，這些解決方案可以減少對外包的依賴並加快計劃進度，尤其是在快節奏的生物技術環境中。自動化合成儀擴大融入實驗室工作流程，再加上經濟高效的耗材的開發，使得中型實驗室和新興企業更容易獲得DNA合成。有利於個人化醫療和精準診斷的監管趨勢也刺激了能夠生產用於靶向檢測開發和臨床研究的 DNA 的合成儀的開發。此外，合成儀製造商、學術機構和製藥公司之間的策略聯盟正在加速產品創新和分銷。基於酶和晶片的系統等下一代合成技術的出現正在提高永續性、精確度和擴充性，開闢了新的商業性途徑。最後，人們對生物技術教育和人才發展的興趣日益濃厚，正在創造對學術合成儀和培訓套件的需求，確保長期的市場擴張。因此，DNA 合成儀被定位為支持基因組科學和生物工程下一個前沿的基礎技術。

部分

類型（桌上型 DNA 合成儀、大型 DNA 合成儀）、應用（藥物發現和研發、基因工程、臨床診斷）、最終用途（學術和研究機構最終用途、製藥和生物技術公司最終用途、臨床實驗室最終用途）

受訪公司範例

  • Agilent Technologies, Inc.
  • Applied Biosystems（Thermo Fisher Scientific）
  • ATDBio Ltd.
  • ATG：biosynthetics GmbH
  • ATUM
  • Azenta Life Sciences
  • BaseClear BV
  • BioAutomation Corporation
  • Biolegio BV
  • Biosearch Technologies（LGC Group）
  • Bioneer Corporation
  • Biotage AB
  • Biosynthesis, Inc.
  • CSBio Company, Inc.
  • DNA Script
  • Eurofins Genomics
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.（IDT）
  • Kilobaser GmbH
  • LGC Biosearch Technologies

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP30560

Global DNA Synthesizer Market to Reach US$787.8 Million by 2030

The global market for DNA Synthesizer estimated at US$322.5 Million in the year 2024, is expected to reach US$787.8 Million by 2030, growing at a CAGR of 16.1% over the analysis period 2024-2030. Benchtop DNA Synthesizers, one of the segments analyzed in the report, is expected to record a 17.9% CAGR and reach US$549.8 Million by the end of the analysis period. Growth in the Large-scale DNA Synthesizers segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$84.8 Million While China is Forecast to Grow at 15.0% CAGR

The DNA Synthesizer market in the U.S. is estimated at US$84.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$121.1 Million by the year 2030 trailing a CAGR of 15.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.0% and 13.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.6% CAGR.

Global DNA Synthesizer Market - Key Trends & Drivers Summarized

Is Synthetic DNA the Fuel Behind the Next Wave of Biotech Innovation?

The rising demand for synthetic DNA is driving a paradigm shift across the biotechnology landscape, with DNA synthesizers positioned at the heart of this transformation. DNA synthesizers, which enable the automated assembly of custom DNA sequences, have become indispensable tools for research, diagnostics, therapeutics, and industrial biotechnology. As synthetic biology gains momentum, scientists are using synthesized DNA to design gene circuits, create novel organisms, and build entire genomes from scratch. The ability to rapidly produce oligonucleotides and gene fragments with high accuracy is accelerating research in CRISPR gene editing, mRNA therapeutics, vaccine development, and metabolic engineering. COVID-19, for example, underscored the value of synthetic DNA in vaccine development, as researchers leveraged synthesizers to quickly prototype viral genes for antigen production. Furthermore, as the cost of DNA synthesis continues to decline, more institutions and biotech startups are integrating synthesizers into their labs to reduce outsourcing costs and enhance project turnaround times. Academic institutions, pharmaceutical companies, and contract research organizations (CROs) are increasingly relying on in-house synthesis capabilities for more flexible and high-throughput workflows. DNA synthesizers are now enabling a shift from single-gene synthesis to large-scale DNA manufacturing for genome assembly, gene libraries, and DNA-based data storage experiments. This growing demand for synthetic DNA in nearly every domain of life sciences positions DNA synthesizers as a strategic technology driving the future of research, innovation, and biomanufacturing.

How Are Technological Advancements Enhancing DNA Synthesis Speed, Accuracy, and Scale?

DNA synthesizer technologies have advanced significantly in recent years, with innovations aimed at improving speed, accuracy, yield, and scalability. Traditional phosphoramidite-based solid-phase synthesis has long been the gold standard for short oligonucleotides, but it faces limitations in sequence length and error accumulation. To overcome these barriers, emerging techniques such as enzymatic DNA synthesis are gaining attention. These methods use engineered polymerases and template-free reactions to synthesize longer and more accurate DNA strands under milder, aqueous conditions-offering potential breakthroughs in both sustainability and efficiency. Additionally, microarray-based synthesis platforms now allow parallel production of thousands of DNA sequences on a single chip, reducing costs and supporting large-scale applications like gene libraries and screening assays. Integration with robotics and automation has made DNA synthesizers more user-friendly, enabling walkaway synthesis with minimal human intervention. Real-time monitoring systems and advanced quality control tools-such as mass spectrometry and capillary electrophoresis-are being incorporated into next-generation synthesizers to ensure product purity and yield. AI and machine learning algorithms are also being utilized to predict synthesis errors and optimize protocols in real time, increasing reproducibility and customization. These innovations are expanding the reach of DNA synthesis beyond standard laboratory use to clinical research, precision medicine, and industrial-scale production. By pushing the boundaries of what can be synthetically engineered, modern DNA synthesizers are playing a crucial role in reshaping the pace and potential of genomic science.

Is the Broadening End-User Base Reshaping Commercial Strategies in the DNA Synthesizer Market?

The DNA synthesizer market is experiencing significant diversification in its end-user base, which is prompting manufacturers to tailor their technologies and services to suit varying levels of expertise, application focus, and throughput needs. Academic institutions and core research labs remain key users, utilizing synthesizers for fundamental genetic and cellular biology research. However, the market is witnessing a sharp rise in adoption among pharmaceutical companies, diagnostics firms, and synthetic biology startups that require high-volume, application-specific DNA synthesis for clinical trials, therapeutic development, and product innovation. Companies working in the fields of agriculture, industrial enzymes, and biofuels are also using DNA synthesizers to optimize genetically modified organisms (GMOs) and microbial production systems. The growing interest in DNA data storage is creating a niche segment of high-capacity synthesizers tailored for encoding digital data into DNA strands. As demand diversifies, commercial strategies are evolving: manufacturers now offer benchtop synthesizers for low-throughput labs, high-capacity platforms for industrial users, and cloud-based synthesis-as-a-service models for institutions seeking access without owning physical equipment. These service models are particularly popular among startups and academic researchers looking for cost-effective access to high-quality DNA without large capital expenditure. Additionally, training programs, software integrations, and on-demand support are becoming integral to commercial offerings, ensuring that users of all levels can effectively operate and maintain synthesizers. By aligning technology with the needs of diverse user groups, companies are strengthening their market position and fostering broader adoption of in-house DNA synthesis capabilities across the life sciences spectrum.

What Are the Key Market Drivers Fueling Demand for DNA Synthesizers Globally?

The growth in the DNA synthesizer market is driven by several interlinked factors rooted in technological innovation, expanding applications, and evolving user demands. One of the primary drivers is the rising adoption of synthetic biology in fields such as therapeutics, agriculture, and bio-manufacturing, where synthetic DNA is foundational to designing biological systems and custom organisms. The need for rapid prototyping in vaccine development, especially mRNA and DNA-based platforms, is also fueling investment in high-throughput DNA synthesis equipment. Additionally, the global expansion of CRISPR and gene editing research is driving the need for precision-engineered guide RNAs and donor templates, further boosting synthesizer usage. Another growth factor is the demand for decentralized, in-house DNA synthesis solutions that reduce dependency on outsourcing and accelerate project timelines-especially important in fast-paced biotech environments. The increasing integration of automated synthesizers into lab workflows, coupled with the development of cost-effective consumables, is making DNA synthesis more accessible to mid-sized labs and startups. Regulatory trends favoring personalized medicine and precision diagnostics are also stimulating the development of synthesizers that can produce DNA for targeted assay development and clinical research. Furthermore, strategic collaborations between synthesizer manufacturers, academic institutions, and pharmaceutical companies are accelerating product innovation and distribution. The advent of next-generation synthesis technologies, such as enzymatic and chip-based systems, is opening new commercial avenues with improved sustainability, accuracy, and scalability. Lastly, the growing focus on biotechnology education and workforce development is creating demand for academic synthesizers and training kits, ensuring long-term market expansion. Together, these diverse yet converging drivers are positioning DNA synthesizers as a cornerstone technology powering the next frontier of genomic science and bioengineering.

SCOPE OF STUDY:

The report analyzes the DNA Synthesizer market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Benchtop DNA Synthesizers, Large-scale DNA Synthesizers); Application (Drug Discovery & Development Application, Genetic Engineering Application, Clinical Diagnostics Application); End-Use (Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use, Clinical Laboratories End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Agilent Technologies, Inc.
  • Applied Biosystems (Thermo Fisher Scientific)
  • ATDBio Ltd.
  • ATG:biosynthetics GmbH
  • ATUM
  • Azenta Life Sciences
  • BaseClear B.V.
  • BioAutomation Corporation
  • Biolegio B.V.
  • Biosearch Technologies (LGC Group)
  • Bioneer Corporation
  • Biotage AB
  • Biosynthesis, Inc.
  • CSBio Company, Inc.
  • DNA Script
  • Eurofins Genomics
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc. (IDT)
  • Kilobaser GmbH
  • LGC Biosearch Technologies

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • DNA Synthesizer - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Boom in Synthetic Biology and Genomic Engineering Throws the Spotlight on Automated DNA Synthesis Platforms
    • Rising Demand for Custom Genes and Oligonucleotides Propels Growth in On-Demand DNA Synthesizer Adoption
    • Declining Cost of DNA Synthesis Strengthens Business Case for In-House Synthesizer Integration
    • Advancements in Enzymatic and Chip-Based Synthesis Methods Accelerate Market Transition from Traditional Chemistries
    • Integration of DNA Synthesizers with Lab Automation Systems Drives Efficiency in High-Throughput Workflows
    • Proliferation of CRISPR and Gene Editing Applications Expands Use of Synthesizers in Research and Therapeutics
    • Growing Role of DNA in Data Storage and Nanotechnology Opens New Commercial Avenues for DNA Synthesizer Technologies
    • Academic and Biotech Startups Turn to Benchtop Synthesizers to Reduce Outsourcing and Speed R&D Cycles
    • Rising Demand for Synthetic Gene Libraries Spurs Need for Scalable, Multiplexed Synthesis Platforms
    • Use of AI for Sequence Optimization Enhances Accuracy, Customization, and Yield of Synthesized DNA
    • Growth in Vaccine Development and mRNA Therapeutics Generates Demand for Rapid and Flexible DNA Synthesis
    • Expansion of Biofoundries and Distributed Manufacturing Models Strengthens Demand for Modular Synthesizer Units
    • Global Investment in Synthetic Genomics Research Sustains Long-Term Growth Opportunities for DNA Synthesizer Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DNA Synthesizer Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DNA Synthesizer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for DNA Synthesizer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for DNA Synthesizer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Benchtop DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Benchtop DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Benchtop DNA Synthesizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Large-scale DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Large-scale DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Large-scale DNA Synthesizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Genetic Engineering Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Clinical Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for DNA Synthesizer by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for DNA Synthesizer by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of World 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION